Last data update: 24 January 2024 16:39 CET
Plasmid name: pCAGGS-Flag-IKKalpha-deltaLZ (LMBP 5489)
New search | Print data sheet |
Price category: | Cat. 1 (cf. price list) |
Status: | GeneCorner core plasmid |
GeneCorner sequence: |
p5489.gb
(View with Genome Compiler) p5489.txt p5489.pdf |
Sequence analysis results Genecorner: |
- |
Cloned DNA: |
Human NF-κB inhibitor kinase α cDNA (IKKα, CHUK, IKBKA); with deletion of the leucine zipper structure (IKKα-ΔLZ) FLAG epitope tag; N-terminal |
Promoter: | Chicken β-actin/rabbit β-globin hybrid promoter (AG) Human cytomegalovirus immediate early promoter (CMV-IE); enhancer only Escherichia coli lac operon promoter |
Ribosome binding site: |
- |
Terminator: | Rabbit β-globin polyadenylation signal (β-globin polyA) Simian virus 40 polyadenylation signal (SV40 polyA) |
Selection marker: | Ampicillin (amp) |
Replicon: | Escherichia coli plasmid pMB1 origin Simian virus 40 bidirectional origin (SV40) |
Host range: | Escherichia coli Mammalian cells; SV40 permissive cells |
Parental clone: | pCAGGS-FLAGmA20; pCAGGS |
Further information: | The plasmid was constructed by ligating the three following fragments: 1) the 2138 bp KpnI-XhoI digested PCR fragment, containing the hIKKα-ΔLZ coding sequence; 2) the 2473 bp KpnI-FspI fragment from pCAGGS-FLAGmA20; 3) the 2369 bp XhoI-FspI-ApaI fragment from pCAGGS. As a result of the deletion of the leucin zipper structure, a NheI site was created. Consequently, no dimerisation can occur. pCAGGS-Flag-IKKalpha-deltaLZ is useful for highly efficient expression of hIKKα-ΔLZ under the control of the AG promoter and the human CMV-IE enhancer in various mammalian cells. The nucleotide sequence of this plasmid corresponds with the EMBL Nucleotide Sequence Database accession number LT726916.1. The nucleotide sequence of the hIKKα cDNA corresponds with the Genbank accession number NM_001278.3. Other name of the plasmid is pCAGGS-Flag-IKKα- ΔLZ. |
EMBL Accession number: | NM_001278.3, view at GenBank LT726916.1, view at EMBL, GenBank, DDBJ |
Latest sequence update: | 06/04/2007 |
Sequence detail: | Primers used to amplify hIKKalpha: 1 5 forward primer: 5' GGAATTCGGTACC.ATG.GAG.CGG.CCC.CCG 3' EcoRI KpnI *** BglI NcoI SmaI 745 741 reverse primer: 5' CCGCTCGAG.TCA.TTC.TGT.TAA.CCA.ACT.CC 3' XhoI +++ HindII Primers used to delete the leucin zipper structure: 450 451 486 490 forward primer: 5' GGA.CAA.AGG.GCA.GCT.AGC.ATT.CAG.CTT.GAC.TTG.G 3' ^ NheI reverse primer: 5' GTC.AAG.CTG.AAT.GCT.AGC.TGC.CCT.TTG.TCC.CTG 3' NheI^ 449 450 451 452 453 wild-type sequence: ... AGG.GCA.GCA.ATG.TTA ... BsrDI ***: start codon. +++: termination codon. ^ : mutated nucleotide. Punctuation indicates reading frame. |
Authenticity test: | Restriction enzyme pattern analysed at GeneCorner: Alw44I, ApaI/PvuII, KpnI, NcoI/NheI, NotI/XhoI and PvuI/XbaI. As compared to the compiled nucleotide sequence, the restriction site analysis pattern revealed that ApaI only cuts twice instead of three times. The ApaI site at position 5758 could not be experimentally confirmed. |
Class: | Recombinant plasmid |
Type: | Plasmid |
History of deposit: | This plasmid was deposited by Dr K. Heyninck(1) (2) and Prof. Dr R. Beyaert(1) (2). It was constructed by M. Kreike(1) (2). (1) Department for Molecular Biomedical Research, VIB, Ghent, Belgium (2) Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium |
Plasmid reference: | - |
Restricted distribution: | - BCCM MTA |
Distributed as: | H/P active culture or plasmid DNA |
Host for distribution: | Escherichia coli K12 MC1061 |
Host reference: | Casadaban et al., J. Mol. Biol. 138 (1980), 179-207 [PMID: 6997493] |
Related host reference: | Brigé et al., Biochem. J. 394 (2006), 335-344 [PMID: 16293111] |
Cultivation medium: | LB-Lennox + ampicillin (100 μg/ml) |
Cultivation temperature: | 37°C |
Biosafety level: | L1 |
Cultivation remark: | - |
Other culture collection numbers: | - |
Refer in your Materials and Methods: |
pCAGGS-Flag-IKKalpha-deltaLZ (LMBP 5489) is available at BCCM/GeneCorner. This plasmid was deposited by Dr K. Heyninck and Prof. Dr R. Beyaert . |
Note: Up-to-date, validated data are enclosed with the biological material. Nevertheless, these data are a snapshot at a given moment; further updates are always possible.